ARTV
Artiva Biotherapeutics, Inc.
Key Financials
Revenue
$0
↓ 100.0%
Operating Income
$-89810000
↓ 33.5%
Net Income
$-83865000
↓ 28.3%
EPS (Diluted)
$-3.43
↑ 41.0%
Total Liabilities
$21.0M
↓ 8.6%
Total Assets
$130.9M
↓ 37.5%
Cash & Equivalents
$26.7M
↓ 33.6%
Shareholders' Equity
$110.0M
↓ 41.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 8-K | 5/19/2026 | View on SEC |
| 144 | 5/18/2026 | View on SEC |
| 144 | 5/18/2026 | View on SEC |
| 144 | 5/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ARTV |
| Company Name | Artiva Biotherapeutics, Inc. |
| CIK | 1817241 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 267-4467 |